Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Why CMC readiness is becoming central to biopharma licensing deals
CMC readiness is becoming critical in biopharma licensing as partners demand proof an asset can be transferred, scaled and supplied
Read Full Article
Express Pharma
Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore
In a regulatory filing, the company said the transaction was completed on August 31, 2026 The post Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore appeared first on Express Pharma.
Read Full Article
Pharma Tech
Trump lines up MFN deals with nine mid-size pharmas on drug pricing push
These White House deals will require the nine midsize pharma companies to provide MFN prices to state Medicaid programmes nationally.
Read Full Article
Pharma Tech
Eli Lilly continues near-monthly M&A presence with $2.9bn Merida deal
Merida's lead programme, MER511, is in Phase I development for Graves' disease and thyroid eye disease (TED).
Read Full Article
Pharma Tech
PharmaEssentia’s Besremi receives FDA approval for ET
The US FDA has approved PharmaEssentia’s Besremi (ropeginterferon alfa-2b-njft) to treat adults with essential thrombocythaemia (ET).
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Pharma Tech
Sep 1, 2026, 1:59 PM
Why CMC readiness is becoming central to biopharma licensing deals
CMC readiness is becoming critical in biopharma licensing as partners demand proof an asset can be transferred, scaled and supplied
PharmaShots
Sep 1, 2026, 12:30 PM
CorTec Receives Second FDA Breakthrough Device Designation for Brain Interchange system
Shots: Ref: Cortec | Image: Cortec | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post CorTec Receives Second FDA Breakthrough Device Designation for Brain Interchange system appeared first on PharmaShots.
PharmaShots
Sep 1, 2026, 12:30 PM
Key Biosimilars Events of August 2026
Shots: Company: Biocon Product: Yesafili Active Ingredient: Aflibercept Reference Product: Eylea Reference Product Company: Bayer Disease: All Approved Indications Date: Aug 03, 2026 Shots: Company: Fresenius Kabi & Dr Reddy’s Laboratories Product: Rituximab Active Ingredient: Rituximab Reference Product: Rituxan Reference Product Company: Genentech & Biogen Disease: All Approved Indications Date: Aug 03, 2026 Shots: Company: Samsung Bioepis Product: Opuviz Active Ingredient: Aflibercept Reference Product: Eylea Reference Product Company: Bayer Disease: All Approved Indications Date: Aug 10, 2026 Shots: … The post Key Biosimilars Events of August 2026 appeared first on PharmaShots.
ET Pharma
Sep 1, 2026, 12:16 PM
Cipla licenses cancer bispecific from China’s Sino Biopharma
Under the agreement, the chinese drugmaker is entitled to receive up to $123 million in upfront, development and regulatory milestone along with double-digit royalties on annual sales.
Express Pharma
Sep 1, 2026, 11:54 AM
Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore
In a regulatory filing, the company said the transaction was completed on August 31, 2026 The post Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore appeared first on Express Pharma.
PharmaShots
Sep 1, 2026, 11:30 AM
HUTCHMED Reports P-III Trial Data on Orpathys + Tagrisso for Previously Untreated MET-Overexpressing EGFRm NSCLC
Shots: Ref: Globenewswire | Image: AstraZeneca & Hutchmed | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post HUTCHMED Reports P-III Trial Data on Orpathys + Tagrisso for Previously Untreated MET-Overexpressing EGFRm NSCLC appeared first on PharmaShots.
News
Latest industry coverage
Google News
Sep 1, 2026, 2:26 PM
Europe's biotech strategy must catch up to avoid discovery without scale - The Parliament Magazine
Europe's biotech strategy must catch up to avoid discovery without scale The Parliament Magazine
Google News
Sep 1, 2026, 2:26 PM
The way forward must be the European way - The Parliament Magazine
The way forward must be the European way The Parliament Magazine
Google News
Sep 1, 2026, 2:17 PM
Why CMC readiness is becoming central to biopharma licensing deals - Pharmaceutical Technology
Why CMC readiness is becoming central to biopharma licensing deals Pharmaceutical Technology
Google News
Sep 1, 2026, 2:13 PM
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1 - PharmTech.com
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1 PharmTech.com
Google News
Sep 1, 2026, 2:04 PM
Optimising microbiology practices: ensuring product safety and regulatory compliance - European Pharmaceutical Review
Optimising microbiology practices: ensuring product safety and regulatory compliance European Pharmaceutical Review
Google News
Sep 1, 2026, 1:59 PM
Simcere Zaiming Licenses Sim0660 to Roche for $1.53 billion - Pharmaceutical Executive
Simcere Zaiming Licenses Sim0660 to Roche for $1.53 billion Pharmaceutical Executive
Google News
Sep 1, 2026, 1:55 PM
Molecular Targeting Technologies Receives Pharma Tech Outlook’s 2026 “Radiopharmaceutical Therapy Solution of the Year” Award for EvaThera - BioSpace
Molecular Targeting Technologies Receives Pharma Tech Outlook’s 2026 “Radiopharmaceutical Therapy Solution of the Year” Award for EvaThera BioSpace
Google News
Sep 1, 2026, 1:50 PM
The Race to Greener Pharma - BioSpectrum Asia
The Race to Greener Pharma BioSpectrum Asia
Google News
Sep 1, 2026, 1:36 PM
MEMO: Trump Has Done Nothing But Sell Out Americans To Enrich Big Drug Companies - Protect Our Care
MEMO: Trump Has Done Nothing But Sell Out Americans To Enrich Big Drug Companies Protect Our Care
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer